Peer Reviewed Articles 2010
-
Joly, Y., Braker, M., Le Huynh, M., “Genetic discrimination in private insurance: global perspectives” 29:4 (2010) New Genetics and Society, 351-368.
-
Joly, Y., Caulfield, T., Knoppers, B.M., Harmsen, E., Pastinen, T., “The Commercialization of Genomic Research in Canada” 6:2 (2010) Healthcare Policy, 24-32.
-
Madadi, P., Joly, Y., Avard, D., Chitayat, D., [...] Koren, G., “Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits” 88:6 (2010) Clinical Pharmacology & Therapeutics, 792–795.
-
Joly, Y., “Clinical Translation of Stem Cell Therapies – Intellectual Property and Anticipatory Governance” 7:2 (2010) SCRIPTed, 265-273.
-
Joly, Y., “Open Biotechnology: Licenses Needed” 28:5 (2010) Nature Biotechnology, 417-419.
-
Hudson, T.J., […], Joly, Y. et al., “International Network of Cancer Genome Projects” 464:7291 (2010) Nature, 993-998.
-
Joly, Y., McClellan, K.A., Knoppers, B.M., “Personalized Vaccines and Public Health Genomics: Anticipating and Monitoring the ELSIs” 8:1 (2010) Current Pharmacogenomics and Personalized Medicine, 4-6.
-
Joly, Y., Ramos-Paque, E., “Approval of New Pharmacogenomic Tests: Is the Canadian Regulatory Process Adequate?” 8:2 (2010) Canadian Journal of Law and Technology, 215-241.